Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bausch Health Companies Inc. Common Stock
(NY:
BHC
)
7.705
+0.095 (+1.25%)
Streaming Delayed Price
Updated: 2:31 PM EST, Dec 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bausch Health Companies Inc. Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
August 01, 2022
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings...
Via
Benzinga
'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst
July 26, 2022
Via
Benzinga
Expert Ratings for Bausch Health Companies
July 26, 2022
Bausch Health Companies (NYSE:BHC) has observed the following analyst ratings within the last quarter:
Via
Benzinga
BHC Stock Continues to Fall as Bausch Health Responds to Court Decision
July 29, 2022
Although Bausch Health promises to fight back against an unfavorable patent protection ruling, BHC stock is still hurting.
Via
InvestorPlace
Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session
July 29, 2022
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
July 29, 2022
Via
Benzinga
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
July 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga Before The Bell: Apple's Strong China Revenue, Amazon's EV Partnership, Jack Ma To Cede Control Of Ant Financial And Other Top Financial Stories Friday, July 29
July 29, 2022
Reuters Tencent’s Overseas Ambitions Face Resistance From India
Via
Benzinga
Bausch Health To Appeal Expected Court Decision On Xifaxan Patents
July 29, 2022
Yesterday, Bausch Health Companies Inc (NYSE: BHC) stock closed 50% lower after the reports on the order on patent litigation over Xifaxan (rifaximin).
Via
Benzinga
Nasdaq Rises 100 Points; US Economy Shrinks Again In Q2
July 28, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday.
Via
Benzinga
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
July 29, 2022
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...
Via
Benzinga
Why Bausch Health's Market Cap Is Being Cut In Half Thursday: 'A Near Worst-Case Scenario'
July 28, 2022
Shares of global health company Bausch Health Companies Inc (NYSE: BHC) are plunging Thursday after a Delaware federal judge issued an oral order on patents related to the company's Xifaxan drug.
Via
Benzinga
Bausch Health (BHC) Stock Plunges 50% on Patent News
July 28, 2022
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
July 28, 2022
On Thursday, 108 companies set new 52-week lows.
Via
Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
July 28, 2022
Gainers
Via
Benzinga
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
July 28, 2022
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan.
Via
Benzinga
Nasdaq Dips Over 100 Points; Meta Earnings Miss Estimates
July 28, 2022
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Thursday.
Via
Benzinga
NIO Stock Falls as Grizzly Research Targets the EV Maker in New Short Report
June 28, 2022
Shares of NIO stock are sinking lower today following the release of a Grizzly Research short report. Here's what you should know.
Via
InvestorPlace
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
June 27, 2022
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...
Via
Benzinga
Opening Day: Golden Sun Rises In Debut As Ivanhoe Electric Delays IPO
June 26, 2022
Chinese tutorial services provider Golden Sun Education opened for trading this week, with its shares surging almost 300% following a $17.6 million initial public offering. Meanwhile, Ivanhoe Electric...
Via
Talk Markets
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
June 24, 2022
Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
Via
Benzinga
Bausch Health to Postpone Its Planned Initial Public Offering (Ipo) of Its Solta Medical Skin-care Division Due to Market Instability.
June 17, 2022
The IPO process for Solta drew "substantial investor interest," according to a statement released by Bausch Health. "However, the business
Via
Best Stocks
Topics
Initial Public Offering
Exposures
Securities Market
Cramer Gives His Opinion On Equinix, Bausch Health And More
June 15, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Bausch Health Companies Inc.
Via
Benzinga
Bausch Health Companies Earnings Perspective: Return On Capital Employed
June 09, 2022
Benzinga Pro data, Bausch Health Companies (NYSE:BHC) reported Q1 sales of $1.92 billion. Earnings fell to a loss of $66.00 million, resulting in a 191.67% decrease from last quarter.
Via
Benzinga
Looking Into Bausch Health Companies's Return On Capital Employed
June 07, 2022
Bausch Health Companies (NYSE:BHC) brought in sales totaling $1.92 billion during Q1 according to data provided by Benzinga Pro. However, earnings decreased 191.67%, resulting in a loss of $66.00...
Via
Benzinga
3 Value Stocks That Could 2x in a Recession
June 02, 2022
It might be tempting to say that valuation metrics are no longer useful for certain kinds of value stocks, but you need to adjust your focus.
Via
InvestorPlace
Billionaire Carl Icahn Is Betting Big on These 5 Stocks. Here’s Why.
June 01, 2022
Famed corporate raider Carl Icahn still manages a billion dollar portfolio for his family office. Here's what he's betting on.
Via
InvestorPlace
Jim Cramer Shares His Opinion On Roblox, Century Aluminum And More
June 01, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Roblox Corp (NASDAQ: RBLX) as it is not making money.
Via
Benzinga
NYSE:BHC Investor Notice: Investigation over Possible Securities Laws Violations by Bausch Health Companies Inc.
May 18, 2022
San Diego, CA -- (SBWIRE) -- 05/18/2022 -- Bausch Health Companies Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
103 Biggest Movers From Yesterday
May 11, 2022
Gainers
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.